We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Boxed Warning For Elidel and Protopic
FDA Approves Boxed Warning For Elidel and Protopic
February 1, 2006
The FDA has approved a boxed warning about possible cancer risks linked to two topical eczema drugs: Novartis' Elidel cream and Astellas Pharma's Protopic ointment.